360iResearch Logo
Global Neuralgia Treatment Market
Report Code: MRR-50AD649 | Publishing Date: September 2020 | Number of Pages: 163

The Global Neuralgia Treatment Market to grow from USD 691.67 Million in 2019 to USD 1,301.31 Million by 2025, at a Compound Annual Growth Rate (CAGR) of 11.10%.

Market Segmentation & Coverage:

The research report categorizes the Neuralgia Treatment Market to forecast the revenues and analyze the trends in each of the following segments:

Based on Treatment Type, the Neuralgia Treatment Market studied across Drug Based and Surgery. The Drug Based further studied across Anticonvulsant Medicines and Tricyclic Antidepressants. The Surgery further studied across Balloon Compression, Glycerol Injection, Microvascular Decompression, Radiofrequency Thermal Lesioning, and Stereotactic Radiosurgery.

Based on Indication, the Neuralgia Treatment Market studied across Diabetic Neuropathy, Intercostal Neuralgia, Occipital Neuralgia, Peripheral Neuralgia, Postherpetic Neuralgia, and Trigeminal Neuralgia.

Based on Distribution Channel, the Neuralgia Treatment Market studied across Drug Stores, Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.

"The Asia-Pacific is projected to witness the highest growth during the forecast period"

Based on Geography, the Neuralgia Treatment Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Americas commanded the largest size in the Neuralgia Treatment Market in 2019, followed by the Europe, Middle East & Africa. On the other hand, the Asia-Pacific expected to grow at the fastest CAGR during the forecast period, followed by the Europe, Middle East & Africa.

Market Dynamics:

The factors attributing to the growth of the market are government initiatives to spread awareness regarding neuralgia treatment products and increasing incidences of neuralgia due to the rise in the aging population. However, some factors such as high-cost associated with the treatment of neuralgia may hinder the market growth. The Neuralgia Treatment Market expected to showcase the opportunities such as developing surgical and pharmacological treatment in developing economies and technological advancement eliminates the need for drugs and surgery. Soon market may face the possible challenges in the growth due to persistent side effects from medications. However, the key players in the market are putting regressive efforts to provide innovative offerings and benchmark strategies in the market.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

360iResearch Competitive Strategic Window:

The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

360iResearch FPNV Positioning Matrix:

The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Neuralgia Treatment Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Company Usability Profiles:

The Neuralgia Treatment Market is highly competitive and characterized by the presence of a large number of international and regional players in the market. The market has witnessed increased competition between vendors based on the pricing model, technology differentiation, brand name, quality of service, price differentiation, and technical expertise.

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Neuralgia Treatment Market, including Biogen Inc., Cadila Healthcare Limited, Cephalon Inc., GlaxoSmithKline PLC, GLENMARK PHARMS LTD., H. Lundbeck A/S, Janssen Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., LGM Pharma LLC, Lupin Limited, Novartis AG, Pfizer Inc., Psychotropics India Limited, Takeda Pharmaceutical Company Limited, Teikoku Pharma USA, Inc., Teva Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., and UCB Group.

  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & Coverage
    3. Years Considered for the Study
    4. Currency & Pricing
    5. Language
    6. Stakeholders
  2. Research Methodology
    1. Research Process
      1. Define: Research Objective
      2. Determine: Research Design
      3. Prepare: Research Instrument
      4. Collect: Data Source
      5. Analyze: Data Interpretation
      6. Formulate: Data Verification
      7. Publish: Research Report
      8. Repeat: Report Update
    2. Research Execution
      1. Initiation: Research Process
      2. Planning: Develop Research Plan
      3. Execution: Conduct Research
      4. Verification: Finding & Analysis
      5. Publication: Research Report
    3. Research Outcome
  3. Executive Summary
    1. Introduction
    2. Market Outlook
    3. Indication Outlook
    4. Distribution Channel Outlook
    5. Treatment Type Outlook
    6. Geography Outlook
    7. Competitor Outlook
  4. Market Overview
    1. Introduction
  5. Market Dynamics
    1. Introduction
    2. Drivers
      1. Increasing incidences of neuralgia due to the rise in the aging population
      2. Government initiatives to spread awareness regarding neuralgia treatment products
    3. Restraints
      1. High-cost associated with the treatment of neuralgia
    4. Opportunities
      1. Technological advancement eliminates the need for drugs and surgery
      2. Developing surgical and pharmacological treatment in developing economies
    5. Challenges
      1. Persistent side effects from medications
  6. Market Insights
    1. Porters Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    2. Cumulative Impact of COVID-19
    3. Client Customizations
      1. Regulatory Framework
  7. Global Neuralgia Treatment Market, By Treatment Type
    1. Introduction
    2. Drug Based
      1. Anticonvulsant Medicines
      2. Tricyclic Antidepressants
    3. Surgery
      1. Balloon Compression
      2. Glycerol Injection
      3. Microvascular Decompression
      4. Radiofrequency Thermal Lesioning
      5. Stereotactic Radiosurgery
  8. Global Neuralgia Treatment Market, By Indication
    1. Introduction
    2. Diabetic Neuropathy
    3. Intercostal Neuralgia
    4. Occipital Neuralgia
    5. Peripheral Neuralgia
    6. Postherpetic Neuralgia
    7. Trigeminal Neuralgia
  9. Global Neuralgia Treatment Market, By Distribution Channel
    1. Introduction
    2. Drug Stores
    3. Hospital Pharmacies
    4. Online Pharmacies
    5. Retail Pharmacies
  10. Americas Neuralgia Treatment Market
    1. Introduction
    2. Argentina
    3. Brazil
    4. Canada
    5. Mexico
    6. United States
  11. Asia-Pacific Neuralgia Treatment Market
    1. Introduction
    2. Australia
    3. China
    4. India
    5. Indonesia
    6. Japan
    7. Malaysia
    8. Philippines
    9. South Korea
    10. Thailand
  12. Europe, Middle East & Africa Neuralgia Treatment Market
    1. Introduction
    2. France
    3. Germany
    4. Italy
    5. Netherlands
    6. Qatar
    7. Russia
    8. Saudi Arabia
    9. South Africa
    10. Spain
    11. United Arab Emirates
    12. United Kingdom
  13. Competitive Landscape
    1. FPNV Positioning Matrix
      1. Quadrants
      2. Business Strategy
      3. Product Satisfaction
    2. Market Ranking Analysis
    3. Market Share Analysis
    4. Competitive Scenario
      1. Merger & Acquisition
      2. Agreement, Collaboration, & Partnership
      3. New Product Launch & Enhancement
      4. Investment & Funding
      5. Award, Recognition, & Expansion
  14. Company Usability Profiles
    1. Biogen Inc.
    2. Cadila Healthcare Limited
    3. Cephalon Inc.
    4. GlaxoSmithKline PLC
    5. GLENMARK PHARMS LTD.
    6. H. Lundbeck A/S
    7. Janssen Pharmaceuticals, Inc.
    8. Johnson & Johnson Services, Inc.
    9. LGM Pharma LLC
    10. Lupin Limited
    11. Novartis AG
    12. Pfizer Inc.
    13. Psychotropics India Limited
    14. Takeda Pharmaceutical Company Limited
    15. Teikoku Pharma USA, Inc.
    16. Teva Pharmaceuticals Ltd.
    17. Torrent Pharmaceuticals Ltd.
    18. UCB Group
  15. Appendix
    1. Discussion Guide

List of Tables

  1. GLOBAL NEURALGIA TREATMENT MARKET SIZE, 2017-2025 (USD MILLION)
  2. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  3. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  4. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DRUG BASED, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  5. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY ANTICONVULSANT MEDICINES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  6. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TRICYCLIC ANTIDEPRESSANTS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  7. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  8. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY BALLOON COMPRESSION, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  9. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY GLYCEROL INJECTION, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  10. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY MICROVASCULAR DECOMPRESSION, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  11. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY RADIOFREQUENCY THERMAL LESIONING, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  12. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY STEREOTACTIC RADIOSURGERY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  13. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  14. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DIABETIC NEUROPATHY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  15. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY INTERCOSTAL NEURALGIA, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  16. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY OCCIPITAL NEURALGIA, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  17. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY PERIPHERAL NEURALGIA, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  18. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY POSTHERPETIC NEURALGIA, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  19. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TRIGEMINAL NEURALGIA, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  20. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  21. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DRUG STORES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  22. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  23. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  24. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  25. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  26. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  27. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  28. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  29. ARGENTINA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  30. ARGENTINA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  31. ARGENTINA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  32. BRAZIL NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  33. BRAZIL NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  34. BRAZIL NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  35. CANADA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  36. CANADA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  37. CANADA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  38. MEXICO NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  39. MEXICO NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  40. MEXICO NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  41. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  42. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  43. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  44. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  45. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  46. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  47. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  48. AUSTRALIA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  49. AUSTRALIA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  50. AUSTRALIA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  51. CHINA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  52. CHINA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  53. CHINA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  54. INDIA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  55. INDIA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  56. INDIA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  57. INDONESIA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  58. INDONESIA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  59. INDONESIA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  60. JAPAN NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  61. JAPAN NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  62. JAPAN NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  63. MALAYSIA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  64. MALAYSIA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  65. MALAYSIA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  66. PHILIPPINES NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  67. PHILIPPINES NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  68. PHILIPPINES NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  69. SOUTH KOREA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  70. SOUTH KOREA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  71. SOUTH KOREA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  72. THAILAND NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  73. THAILAND NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  74. THAILAND NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  75. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  76. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  77. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  78. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  79. FRANCE NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  80. FRANCE NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  81. FRANCE NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  82. GERMANY NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  83. GERMANY NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  84. GERMANY NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  85. ITALY NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  86. ITALY NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  87. ITALY NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  88. NETHERLANDS NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  89. NETHERLANDS NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  90. NETHERLANDS NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  91. QATAR NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  92. QATAR NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  93. QATAR NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  94. RUSSIA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  95. RUSSIA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  96. RUSSIA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  97. SAUDI ARABIA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  98. SAUDI ARABIA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  99. SAUDI ARABIA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  100. SOUTH AFRICA NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  101. SOUTH AFRICA NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  102. SOUTH AFRICA NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  103. SPAIN NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  104. SPAIN NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  105. SPAIN NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  106. UNITED ARAB EMIRATES NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  107. UNITED ARAB EMIRATES NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  108. UNITED ARAB EMIRATES NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  109. UNITED KINGDOM NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  110. UNITED KINGDOM NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2025 (USD MILLION)
  111. UNITED KINGDOM NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2017-2025 (USD MILLION)
  112. GLOBAL NEURALGIA TREATMENT MARKET: SCORES
  113. GLOBAL NEURALGIA TREATMENT MARKET: BUSINESS STRATEGY
  114. GLOBAL NEURALGIA TREATMENT MARKET: PRODUCT SATISFACTION
  115. GLOBAL NEURALGIA TREATMENT MARKET: RANKING
  116. GLOBAL NEURALGIA TREATMENT MARKET: MERGER & ACQUISITION
  117. GLOBAL NEURALGIA TREATMENT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  118. GLOBAL NEURALGIA TREATMENT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  119. GLOBAL NEURALGIA TREATMENT MARKET: INVESTMENT & FUNDING
  120. GLOBAL NEURALGIA TREATMENT MARKET: AWARD, RECOGNITION, & EXPANSION

List of Figures

  1. GLOBAL NEURALGIA TREATMENT MARKET: RESEARCH PROCESS
  2. GLOBAL NEURALGIA TREATMENT MARKET: RESEARCH EXECUTION
  3. GLOBAL NEURALGIA TREATMENT MARKET SIZE, 2019 VS 2025 (USD MILLION)
  4. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2019 VS 2025 (USD MILLION)
  5. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019 VS 2025 (USD MILLION)
  6. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019 VS 2025 (USD MILLION)
  7. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  8. GLOBAL NEURALGIA TREATMENT MARKET SIZE, 2017-2025 (USD MILLION)
  9. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
  10. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
  12. GLOBAL NEURALGIA TREATMENT MARKET: MARKET DYNAMICS
  13. GLOBAL NEURALGIA TREATMENT MARKET: PORTERS FIVE FORCES ANALYSIS
  14. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019 VS 2025 (%)
  15. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019 VS 2025 (USD MILLION)
  16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025
  17. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DRUG BASED, 2019 VS 2025 (USD MILLION)
  18. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY ANTICONVULSANT MEDICINES, 2019 VS 2025 (USD MILLION)
  19. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TRICYCLIC ANTIDEPRESSANTS, 2019 VS 2025 (USD MILLION)
  20. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY SURGERY, 2019 VS 2025 (USD MILLION)
  21. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY BALLOON COMPRESSION, 2019 VS 2025 (USD MILLION)
  22. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY GLYCEROL INJECTION, 2019 VS 2025 (USD MILLION)
  23. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY MICROVASCULAR DECOMPRESSION, 2019 VS 2025 (USD MILLION)
  24. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY RADIOFREQUENCY THERMAL LESIONING, 2019 VS 2025 (USD MILLION)
  25. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY STEREOTACTIC RADIOSURGERY, 2019 VS 2025 (USD MILLION)
  26. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2019 VS 2025 (%)
  27. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2019 VS 2025 (USD MILLION)
  28. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY INDICATION, 2025
  29. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DIABETIC NEUROPATHY, 2019 VS 2025 (USD MILLION)
  30. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY INTERCOSTAL NEURALGIA, 2019 VS 2025 (USD MILLION)
  31. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY OCCIPITAL NEURALGIA, 2019 VS 2025 (USD MILLION)
  32. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY PERIPHERAL NEURALGIA, 2019 VS 2025 (USD MILLION)
  33. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY POSTHERPETIC NEURALGIA, 2019 VS 2025 (USD MILLION)
  34. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY TRIGEMINAL NEURALGIA, 2019 VS 2025 (USD MILLION)
  35. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019 VS 2025 (%)
  36. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019 VS 2025 (USD MILLION)
  37. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025
  38. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY DRUG STORES, 2019 VS 2025 (USD MILLION)
  39. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2019 VS 2025 (USD MILLION)
  40. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2019 VS 2025 (USD MILLION)
  41. GLOBAL NEURALGIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2019 VS 2025 (USD MILLION)
  42. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
  43. AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  44. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
  45. ARGENTINA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  46. BRAZIL NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  47. CANADA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  48. MEXICO NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  49. UNITED STATES NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  50. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
  51. ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  52. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
  53. AUSTRALIA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  54. CHINA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  55. INDIA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  56. INDONESIA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  57. JAPAN NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  58. MALAYSIA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  59. PHILIPPINES NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  60. SOUTH KOREA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  61. THAILAND NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  62. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (%)
  63. EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  64. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
  65. FRANCE NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  66. GERMANY NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  67. ITALY NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  68. NETHERLANDS NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  69. QATAR NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  70. RUSSIA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  71. SAUDI ARABIA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  72. SOUTH AFRICA NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  73. SPAIN NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  74. UNITED ARAB EMIRATES NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  75. UNITED KINGDOM NEURALGIA TREATMENT MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  76. GLOBAL NEURALGIA TREATMENT MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
  77. GLOBAL NEURALGIA TREATMENT MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
  78. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL NEURALGIA TREATMENT MARKET, BY TYPE